Kriya Announces Publication of Preclinical Data for its Investigational AAV-FGF21 Gene Therapy Demonstrating Durable Reversal of Liver Fibrosis
Results demonstrate statistically significant fibrosis reversal and protection against hepatocellular carcinoma in animal models of MASH –– ...
Bryn Mar Athletics8h
Stress and the Brain: Uncovering Sex Differences in Cognitive Flexibility
The National Institute of Mental Health awards a $344,589 grant to Associate Professor and Behavioral Neuroscientist Laura ...
One-time gene therapy reverses liver disease MASH in mouse models
UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver ...
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported business highlights and third quarter 2024 financial results. "This is ...